- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/10 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
Patent holdings for IPC class C07K 16/10
Total number of patents in this class: 5097
10-year publication summary
|
237
|
271
|
284
|
291
|
439
|
551
|
532
|
479
|
297
|
77
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2980 |
143 |
| Vanderbilt University | 1991 |
78 |
| Regeneron Pharmaceuticals, Inc. | 4643 |
77 |
| The Rockefeller University | 580 |
77 |
| The Scripps Research Institute | 1343 |
76 |
| Humabs Biomed SA | 121 |
74 |
| Duke University | 3172 |
61 |
| California Institute of Technology | 4023 |
50 |
| VIR Biotechnology, Inc. | 147 |
47 |
| The Wistar Institute of Anatomy and Biology | 474 |
47 |
| Dana-Farber Cancer Institute, Inc. | 2645 |
40 |
| Academia Sinica | 954 |
36 |
| The Trustees of Columbia University in the City of New York | 3627 |
35 |
| The Trustees of the University of Pennsylvania | 4403 |
35 |
| International AIDS Vaccine Initiative | 90 |
35 |
| Institut Pasteur | 787 |
31 |
| Visterra, Inc. | 124 |
30 |
| Massachusetts Institute of Technology | 10204 |
29 |
| The Regents of the University of California | 20590 |
28 |
| MedImmune, LLC | 497 |
27 |
| Other owners | 4041 |